These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 31738617)

  • 1. Recent developments in pharmacotherapy for hypertriglyceridemia: what's the current state of the art?
    Florentin M; Kostapanos MS; Anagnostis P; Liamis G
    Expert Opin Pharmacother; 2020 Jan; 21(1):107-120. PubMed ID: 31738617
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-chain omega-3 fatty acids, fibrates and niacin as therapeutic options in the treatment of hypertriglyceridemia: a review of the literature.
    Ito MK
    Atherosclerosis; 2015 Oct; 242(2):647-56. PubMed ID: 26296750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in pharmacotherapy for hypertriglyceridemia.
    Sahebkar A; Chew GT; Watts GF
    Prog Lipid Res; 2014 Oct; 56():47-66. PubMed ID: 25083925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigational drugs in development for hypertriglyceridemia: a coming-of-age story.
    Rhainds D; Brodeur MR; Tardif JC
    Expert Opin Investig Drugs; 2019 Dec; 28(12):1059-1079. PubMed ID: 31752565
    [No Abstract]   [Full Text] [Related]  

  • 5. Targeting apoC-III and ANGPTL3 in the treatment of hypertriglyceridemia.
    Nurmohamed NS; Dallinga-Thie GM; Stroes ESG
    Expert Rev Cardiovasc Ther; 2020 Jun; 18(6):355-361. PubMed ID: 32511037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Hypertriglyceridemia: A Review of Therapies in the Pipeline.
    Xu J; Ashjian E
    J Pharm Pract; 2023 Jun; 36(3):650-661. PubMed ID: 34720008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular Disease Risk Reduction in Mild-Moderate Hypertriglyceridemia: Integrating Prescription of Omega-3 with Standard Treatment.
    Picard F; Steg PG
    Curr Atheroscler Rep; 2021 Mar; 23(6):27. PubMed ID: 33788024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of prescription omega-3 fatty acid products for hypertriglyceridemia.
    Weintraub HS
    Postgrad Med; 2014 Nov; 126(7):7-18. PubMed ID: 25387209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of omega-3 carboxylic acids on apolipoprotein CIII-containing lipoproteins in severe hypertriglyceridemia.
    Morton AM; Furtado JD; Lee J; Amerine W; Davidson MH; Sacks FM
    J Clin Lipidol; 2016; 10(6):1442-1451.e4. PubMed ID: 27919362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omega-3 free fatty acids for the treatment of severe hypertriglyceridemia: the EpanoVa fOr Lowering Very high triglyceridEs (EVOLVE) trial.
    Kastelein JJ; Maki KC; Susekov A; Ezhov M; Nordestgaard BG; Machielse BN; Kling D; Davidson MH
    J Clin Lipidol; 2014; 8(1):94-106. PubMed ID: 24528690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale for prescription omega-3-acid ethyl ester therapy for hypertriglyceridemia: a primer for clinicians.
    Bays H
    Drugs Today (Barc); 2008 Mar; 44(3):205-46. PubMed ID: 18536782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Icosapent ethyl: a review of its use in severe hypertriglyceridemia.
    Kim ES; McCormack PL
    Am J Cardiovasc Drugs; 2014 Dec; 14(6):471-8. PubMed ID: 25428605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertriglyceridemia and cardiovascular risk reduction.
    Jacobson TA; Miller M; Schaefer EJ
    Clin Ther; 2007 May; 29(5):763-777. PubMed ID: 17697898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omega-3 carboxylic acids in patients with severe hypertriglyceridemia: EVOLVE II, a randomized, placebo-controlled trial.
    Stroes ESG; Susekov AV; de Bruin TWA; Kvarnström M; Yang H; Davidson MH
    J Clin Lipidol; 2018; 12(2):321-330. PubMed ID: 29289538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in treating hypertriglyceridemia in patients at high risk of cardiovascular disease with apolipoprotein C-III inhibitors.
    Spagnuolo CM; Hegele RA
    Expert Opin Pharmacother; 2023 Jun; 24(9):1013-1020. PubMed ID: 37114828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triglyceride-Rich Lipoproteins and Novel Targets for Anti-atherosclerotic Therapy.
    Reiner Ž
    Korean Circ J; 2018 Dec; 48(12):1097-1119. PubMed ID: 30403015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Review of Clinical Practice Guidelines for the Management of Hypertriglyceridemia: A Focus on High Dose Omega-3 Fatty Acids.
    Karalis DG
    Adv Ther; 2017 Feb; 34(2):300-323. PubMed ID: 27981496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological treatment options for severe hypertriglyceridemia and familial chylomicronemia syndrome.
    Chaudhry R; Viljoen A; Wierzbicki AS
    Expert Rev Clin Pharmacol; 2018 Jun; 11(6):589-598. PubMed ID: 29842811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel therapeutics in hypertriglyceridemia.
    Gryn SE; Hegele RA
    Curr Opin Lipidol; 2015 Dec; 26(6):484-91. PubMed ID: 26780002
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.